Key Findings
The Asia Pacific vascular guidewires market is expected to evolve around CAGR of 5.97% during the estimated period of 2019-2027. The densely populated region, with the presence of developing economies like India and China, provides tremendous opportunities for the vascular guidewires market.

Market Insights
The Asia Pacific market is mainly influenced by the trends of countries, namely South Korea, China, Australia, India, Japan, and Rest of Asia Pacific region that includes other countries from the Pacific Rim. The adoption of urbanization and sedentary lifestyles lead to rising cases of cardiovascular disorders. Therefore, the vascular guidewires market is expected to witness mounting growth in the region owing to rising disposable income and high adoption rates of vascular intervention procedures. As vascular guidewires are a vital part of vascular intervention treatment, the surging adoption will drive the vascular guidewires market. Further, with the technological developments in elements and coating types of guidewires, the market is providing lucrative prospects for the manufacturers.

Competitive Insights
B Braun Melsungen AG, Koninklijke Philips N.V., Boston Scientific Corporation, Abbott, Terumo, Biotronik Se & Co. KG, Olympus Corporation, Merit Medical Systems, Becton Dickinson and Company, and Medtronic, among others, are few companies operating in the vascular guidewires market. The leading companies launch new products along with initiatives like business expansion to hold major market share. Also, as the market comprises vendors ranging from big, medium to small, the market is highly competitive.